Pharmacokinetic and Safety Study of a 90 Day Intravaginal Ring Containing Tenofovir

NCT03670355 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tenofovir (TFV) IVR
DRUG: Placebo IVR

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)